Jae-Weon Kim

62PUBLICATIONS
438CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedCancer geneticsAerospace materialsSurgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Aug 07, 2026
Reconciling modest median progression-free survival and larger overall survival gains in platinum-resistant ovarian cancer.

|May 22, 2026
Equitable authorship in Global Gynecologic Oncology trials: the Asia Pacific Gynecologic Oncology Trials Group (APGOT) framework.

|May 15, 2026
Is chemo-immunotherapy really beneficial for platinum-resistant ovarian cancer?

|Mar 03, 2026
Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations.

Hyunji Lim, Se Ik Kim, Kyung-Jin Min

|Jan 29, 2026
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.

Hyun-Woong Cho, Jeong-Yeol Park, Myong Cheol Lim

|Jan 09, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).

Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi

Pageof 11

Frequent Collaborators

20 joint publications

Dong Hoon Suh

13 joint publications

Jung-Yun Lee

13 joint publications

Myong Cheol Lim

12 joint publications

Jeong-Yeol Park